Pyrazinamide News and Research

RSS
Study provides new insight into how pyrazinamide works

Study provides new insight into how pyrazinamide works

Clinical trial to examine AstraZeneca experimental drug against pulmonary tuberculosis

Clinical trial to examine AstraZeneca experimental drug against pulmonary tuberculosis

TB Alliance and FIND partner to promote development of TB drugs and diagnostics

TB Alliance and FIND partner to promote development of TB drugs and diagnostics

TB combination drug: an interview with Mel Spigelman, MD, CEO and President of TB Alliance

TB combination drug: an interview with Mel Spigelman, MD, CEO and President of TB Alliance

New combination therapy for TB shows promise in Phase II study

New combination therapy for TB shows promise in Phase II study

Novel combination drug regimen could be more effective than existing treatments for TB

Novel combination drug regimen could be more effective than existing treatments for TB

TB combination drug trials progress

TB combination drug trials progress

Inhibiting immune response during initial multi-drug therapy could speed TB treatment time

Inhibiting immune response during initial multi-drug therapy could speed TB treatment time

TB research finds body’s own response helps TB bacteria survive

TB research finds body’s own response helps TB bacteria survive

TB Alliance launches new combination drug trial

TB Alliance launches new combination drug trial

Research into TB medication may shorten treatment regimen

Research into TB medication may shorten treatment regimen

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

Researchers discover key reason why pyrazinamide shortens duration of TB therapy

Researchers discover key reason why pyrazinamide shortens duration of TB therapy

Mayo Clinic licenses M. tuberculosis complex speciation test from QIAGEN

Mayo Clinic licenses M. tuberculosis complex speciation test from QIAGEN

Immunitor completes V5 Phase IIb imm01 clinical trial enrollment for TB

Immunitor completes V5 Phase IIb imm01 clinical trial enrollment for TB

TB Alliance launches three-drug combination trial for drug-sensitive and multidrug-resistant TB

TB Alliance launches three-drug combination trial for drug-sensitive and multidrug-resistant TB

Philippine FDA's LSD attains ISO/IEC 17025:2005 accreditation for testing and calibration laboratories

Philippine FDA's LSD attains ISO/IEC 17025:2005 accreditation for testing and calibration laboratories

Higher drug doses needed to defeat tuberculosis in overweight and obese

Higher drug doses needed to defeat tuberculosis in overweight and obese

Slow-growing tuberculosis bacteria point the way to new drug development

Slow-growing tuberculosis bacteria point the way to new drug development

Rifapentine is back for tuberculosis

Rifapentine is back for tuberculosis